Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Prognostic impact of cytogenetic abnormalities in aggressive T-cell lymphomas: Defining high-risk subgroups through conventional karyotyping.

Ahmad Kiwan, Autumn Diadamo, Jia Di Wen, Tariq Kewan, Alexa Siddon, Shalin Kothari, Iris Isufi, Stuart Seropian, Scott Huntington, Francesca Montanari, Mina Xu, Peining Li, Michael Girardi, Tarsheen Sethi, Francine Foss

Blood (2025) 146 (Supplement 1): 1759.

https://doi.org/10.1182/blood-2025-1759

Published: 2025

Journal Articles

Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma (PTCL): A multicenter retrospective Study

Blood (2025) 146 (Supplement 1): 4523.

https://doi.org/10.1182/blood-2025-4523

Published: 2025

Journal Articles

Pentostatin/TBI conditioning for allogeneic transplantation in T-cell lymphomas

Cristian Taborda, Iris Isufi, Tarsheen Sethi, Noffar Bar, Lohith Gowda, Lynn Wilson, Michael Girardi, Kenneth Roberts, Stuart Seropian, Francine Foss

Blood (2025) 146 (Supplement 1): 2433.

https://doi.org/10.1182/blood-2025-2433

Published: 2025

Journal Articles

Allogeneic stem cell transplant results in t-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort

Blood (2025) 146 (Supplement 1): 1054.

https://doi.org/10.1182/blood-2025-1054

Published: 2025

Journal Articles

Early time-to-relapse as a predictor of survival in mature T-cell/NK-cell lymphomas: Results from the PETAL consortium

Mark Sorial, Kenechukwu Aniagboso, Emily Buttermore, Matthew Lei, Ellen Kendall, Kristiana Nasto, Min Jung Koh, Jessy Xinyi Han, Leora Boussi, Luis Malpica, Brady Beltran, Laura Korin, German Stemmelin, Carlos Chiattone, Denisse Castro, Fabiola Valvert, Jule Vasquez, Henry Quintero, Macarena Roa, Alfredo Quiroz, Marialejandra Torres Viera, Luis Mario Villela Martinez, Ana Oliver, Cesar Augusto Samanez Figari, Edith Julia, Vincent Camus, Catherine Thieblemont, Philippe Gaulard, Laurence de Leval, Franck Morschhauser, Emmanuel Bachy, Omar Elghawy, Stefan Barta, Jack Malespini, Kusha Chopra, Caroline MacVicar, Sean McCabe, Luke Peng, Shambhavi Singh, Makoto Iwasaki, Ijeoma Eche-Ugwu, Judith Gabler, Maria J Fernandez, Alexander Disciullo, Josie Ford, Alexandra Lenart, Emmanuel Nwodo, Jeffrey Barnes, Min Ji Koh, Eliana Miranda, Robert Stuver, Mwanasha Merrill, Eric Jacobsen, Martina Manni, Monica Civallero, Tetiana Skrypets, Athina Lymboussaki, Massimo Federico, Yu Ri Kim, Jin Seok Kim, Jae Yong Cho, Thomas Eipe, Tanuja Shet, Epari Sridhar, Alok Shetty, Saswata Saha, Manju Sengar, Hasmukh Jain, Carrie Van Der Weyden, H. Miles Prince, Ramzi Hamouche, Tinatin Muradashvili, Francine Foss, Marianna Gentilini, Beatrice Casadei, Pier Luigi Zinzani, Takeshi Okatani, Noriaki Yoshida, Sang Eun Yoon, Won-Seog Kim, Girisha Panchoo, Zainab Mohamed, Estelle Verburgh, Jackielyn Cuenca Alturas, Mubarak Al Mansour, Maria Elena Cabrera, Govind Bhagat, Helen Ma, Ahmed Sawas, Dhruv Mistry, Khyati Kariya, Forum Bhanushali, Maya Krishnan, Erica Lee, Owen O'Conner, Enrica Marchi, Devavrat Shah, Changyu Shen, Salvia Jain

Blood (2025) 146 (Supplement 1): 889.

https://doi.org/10.1182/blood-2025-889

Published: 2025

Journal Articles

Concurrent TP53 loss-of-function and epigenetic modifier mutations as a potential predictor of chemoimmunotherapy failure in DLBCL & hgbl

Arjun Ravishankar, Iris Isufi, Scott Huntington, Stuart Seropian, Francine Foss, Tarsheen Sethi, Shalin Kothari

Blood (2025) 146 (Supplement 1): 7071.

https://doi.org/10.1182/blood-2025-7071

Published: 2025

Journal Articles

Frontline chemotherapy for CD30+ non-ALCL peripheral T-cell lymphoma a multi-center retrospective analysis

Blood (2025) 146 (Supplement 1): 3641.

https://doi.org/10.1182/blood-2025-3641

Published: 2025

Journal Articles

Aberrant circulating CD4+ CD26- T-cells in T-cell rich B-cell lymphomas: Diagnostic pitfall or biomarker?

Arjun Ravishankar, Pohan Chen, Mina Xu, Demetrios Braddock, Alexa Siddon, Iris Isufi, Scott Huntington, Stuart Seropian, Francine Foss, Shalin Kothari, Tarsheen Sethi

Blood (2025) 146 (Supplement 1): 7182.

https://doi.org/10.1182/blood-2025-7182

Published: 2025

Journal Articles

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Blood (2022) 140 (5): 419–437.

https://doi.org/10.1182/blood.2021012057

Published: 2022

Journal Articles

A Novel Prognostic Index for Ocular Adnexal Lymphoma

Marshall W. Meeks, BS, Henry S. Park, MD MPH, James B. Yu, MD MHS, Kenneth B. Roberts, MD, Francine Foss, MD, Lynn D. Wilson, MD MPH

Blood (2016) 128 (22): 3597.

https://doi.org/10.1182/blood.V128.22.3597.3597

Published: 2016

Journal Articles

First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)

Blood (2015) 126 (23): 341.

https://doi.org/10.1182/blood.V126.23.341.341

Published: 2015

Journal Articles

Correlation of Target Molecule Expression and Overall Response in Refractory Cutaneous T-Cell Lymphoma Patients Dosed with Mogamulizumab (KW-0761), a Monoclonal Antibody Directed Against CC Chemokine Receptor Type 4 (CCR4)

Madeleine Duvic, MD, Lauren Pinter-Brown, Francine Foss, MD, Lubomir Sokol, MD, PhD, Jeffrey Jorgensen, MD, PhD, Xiao Ni, MD, PhD, Pramoda Challagundla, MS, Meghali Goswami, BS, Karen Dwyer, Nehal Mohamed, PhD, Youn H Kim, MD

Blood (2012) 120 (21): 3697.

https://doi.org/10.1182/blood.V120.21.3697.3697

Published: 2012

Journal Articles

Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma

Steven M. Horwitz, Youn H. Kim, Francine Foss, Jasmine M. Zain, Patricia L. Myskowski, Mary Jo Lechowicz, David C. Fisher, Andrei R. Shustov, Nancy L. Bartlett, Maria L. Delioukina, Tony Koutsoukos, Michael E. Saunders, Owen A. O'Connor, Madeleine Duvic

Blood (2012) 119 (18): 4115–4122.

https://doi.org/10.1182/blood-2011-11-390211

Published: 2012

Journal Articles

Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma

Yingtai Chen, Tongzhang Zheng, Qing Lan, Francine Foss, Christopher Kim, Xuezhong Chen, Min Dai, Yumin Li, Theodore Holford, Brian Leaderer, Peter Boyle, Stephen J. Chanock, Nathaniel Rothman, Yawei Zhang

Blood (2011) 117 (2): 585–590.

https://doi.org/10.1182/blood-2010-07-295097

Published: 2011

Includes: Supplemental data

Journal Articles

Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy

Carole Berger, Kristin Hoffmann, Juan G. Vasquez, Shrikant Mane, Julia Lewis, Renata Filler, Aiping Lin, Hongyu Zhao, Tyler Durazzo, Abigail Baird, William Lin, Francine Foss, Inger Christensen, Michael Girardi, Robert Tigelaar, Richard Edelson

Blood (2010) 116 (23): 4838–4847.

https://doi.org/10.1182/blood-2009-11-256040

Published: 2010

Journal Articles

Complete Responses with Denileukin Diftitox in Cutaneous T-Cell Lymphoma Studies.

Francine Foss, MD, Madeleine Duvic, MD, Elise A. Olsen, MD, Anna Kozlovski, Pharm, D

Blood (2009) 114 (22): 3745.

https://doi.org/10.1182/blood.V114.22.3745.3745

Published: 2009

Journal Articles

Stem Cell Mobilization Using 5 Pm Dosing of Plerixafor.

Dennis L Cooper, MD, Julie Baker, APRN, Erin Medoff, APRN, Kathryn Pratt, RN, Ann Conkling-Walsh, RN, Edward L. Snyder, MD, Stuart Seropian, MD, Francine Foss, MD

Blood (2009) 114 (22): 4233.

https://doi.org/10.1182/blood.V114.22.4233.4233

Published: 2009

Journal Articles

A Retrospective Comparison of Autologous Vs. Allogeneic Transplantation for Peripheral T-Cell Lymphoma: A Single Institution Experience

Frederick Lansigan, MD, Stuart Seropian, Dennis Cooper, Francine Foss

Blood (2008) 112 (11): 4392.

https://doi.org/10.1182/blood.V112.11.4392.4392

Published: 2008

Journal Articles

Should All Patients with Acute Myelogenous Leukemia (AML) Other Than Good Risk Cytogenetics Receive Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in First Remission?

Onder Alpdogan, MD, Raymond Lenox, APRN, Amy Barile, APRN, Francine Foss, MD, Warren Shlomchik, MD, Christy Reuben, APRN, Dennis Cooper, MD, Stuart Seropian, MD

Blood (2008) 112 (11): 4396.

https://doi.org/10.1182/blood.V112.11.4396.4396

Published: 2008

Journal Articles

Outcomes in Subcutaneous Panniculitis-Like T-Cell Lymphoma (STCL)

Onder Alpdogan, MD, Deborah Ornstein, MD, Tony Subtil, MD, Stuart Seropian, MD, Dennis L. Cooper, MD, Francine Foss, MD

Blood (2008) 112 (11): 3750.

https://doi.org/10.1182/blood.V112.11.3750.3750

Published: 2008

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Prognostic impact of cytogenetic abnormalities in aggressive T-cell lymphomas: Defining high-risk subgroups through conventional karyotyping.

Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma (PTCL): A multicenter retrospective Study

Pentostatin/TBI conditioning for allogeneic transplantation in T-cell lymphomas

Allogeneic stem cell transplant results in t-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort

Early time-to-relapse as a predictor of survival in mature T-cell/NK-cell lymphomas: Results from the PETAL consortium

Concurrent TP53 loss-of-function and epigenetic modifier mutations as a potential predictor of chemoimmunotherapy failure in DLBCL & hgbl

Frontline chemotherapy for CD30+ non-ALCL peripheral T-cell lymphoma a multi-center retrospective analysis

Aberrant circulating CD4+ CD26- T-cells in T-cell rich B-cell lymphomas: Diagnostic pitfall or biomarker?

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

A Novel Prognostic Index for Ocular Adnexal Lymphoma

First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)

Correlation of Target Molecule Expression and Overall Response in Refractory Cutaneous T-Cell Lymphoma Patients Dosed with Mogamulizumab (KW-0761), a Monoclonal Antibody Directed Against CC Chemokine Receptor Type 4 (CCR4)

Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma

Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma

Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy

Complete Responses with Denileukin Diftitox in Cutaneous T-Cell Lymphoma Studies.

Stem Cell Mobilization Using 5 Pm Dosing of Plerixafor.

A Retrospective Comparison of Autologous Vs. Allogeneic Transplantation for Peripheral T-Cell Lymphoma: A Single Institution Experience

Should All Patients with Acute Myelogenous Leukemia (AML) Other Than Good Risk Cytogenetics Receive Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in First Remission?

Outcomes in Subcutaneous Panniculitis-Like T-Cell Lymphoma (STCL)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only